Randomized placebo‐controlled trial of donepezil in cognitive impairment in Parkinson's disease

Iracema Leroi(Trinity College Dublin), Laura Marsh(Michael E. DeBakey VA Medical Center), Richard E. Thompson(Johns Hopkins University), Stephen Grill(Johns Hopkins University), Stephen G. Reich(Johns Hopkins Medicine), Jason Brandt(Johns Hopkins University), Constantine G. Lyketsos(Johns Hopkins University)
International Journal of Geriatric Psychiatry
January 1, 2004
10.1002/gps.993
Cited by 228

Related Papers

Mood Disorders in the Medically Ill: Scientific Review and Recommendations
|Biological Psychiatry|2005|1.1k
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial
|The Lancet|2019|891
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
|The Lancet Neurology|2009|460
Cognitive Impairment in Parkinson Disease
|Journal of Geriatric Psychiatry and Neurology|2012|380
Why Would You Remove Half a Brain? The Outcome of 58 Children After Hemispherectomy—The Johns Hopkins Experience: 1968 to 1996
|PEDIATRICS|1997|261